NeoStem's combined Management Team and Boards of Directors have extensive experience in the healthcare industry. Collectively they have expert experience in the general medical industry, life science marketing, business management, capital raising, licensing, clinical trails, and strategic partnering.

Robin Smith, M.D., MBA, Chairman of the Board, CEO
Dr. Robin L. Smith joined the Company as Chairman of its Advisory Board in September 2005 and, effective June 2, 2006, is the Chief Executive Officer and Chairman of the Board. Dr. Smith, who received a medical degree from Yale University in 1992 and a master’s degree in business administration from the Wharton School in 1997, brings to the Company extensive experience in medical enterprises and business development. MORE>

Mark Weinreb, Board Director, President
Mr. Weinreb, an experienced chief executive officer and public company manager, oversees the Company’s business and strategic initiatives. Mr. Weinreb joined the Company in February 2003 as Chairman of the Board of Directors, President and Chief Executive Officer, and in June 2006 continues as a Director and the Company’s President. MORE>

Larry A. May, Chief Financial Officer
Mr. May, former Treasurer of Amgen (one of the world’s largest biotechnology companies), initially joined Phase III Medical to assist with licensing activities in September 2003. In March of 2006, he was appointed the Company’s Chief Financial Officer. For the last 20 years, Mr. May has worked in the areas of life science and biotechnology. MORE>

Denis Rodgerson, Ph.D., Director of Stem Cell Science
Dr. Rodgerson joined the Company upon the closing of the Company’s acquisition of the business of NeoStem, Inc. (California). Dr. Rodgerson, one of the original founders of NeoStem (California), Inc., has over 36 years’ experience managing large tertiary care and reference clinical laboratories with many patents and articles to his credit. Prior to NeoStem (California), he co-founded StemCyte, and oversaw the company’s growth to become the world’s second largest umbilical cord stem cell bank with multinational collection centers. MORE>

George Smith, M.D., Medical Director of Laboratory Operations, California
Dr. George Smith was appointed NeoStem’s Medical Director of Laboratory Operations, California in January 2006. His responsibilities are to oversee all operations at the Company’s California laboratory, including the processing and storage of autologous adult stem cells procedures, licensing requirements and collection protocols. MORE>

Catherine M. Vaczy, Esq., Vice President and General Counsel
Ms. Vaczy joined the Company in April 2005 as Vice President and General Counsel. Ms. Vaczy is responsible for overseeing the Company’s legal affairs as well as assisting the Company in reviewing and evaluating business, scientific and medical opportunities. MORE>

Arlene Graime,  Director of Government Affairs and Special Projects
Ms. Graime joined the company in March, 2007 and will spearhead initiatives aimed at working with key federal and state agencies, and crucial Congressional committees in order to raise awareness for the benefits of adult stem cell therapy as a treatment option. She will be working with these groups, as well as, other corporations, agencies and organizations to provide resources for First Responders (fire, police, and military) who are at risk of suffering from radiation exposure as well as other diseases. MORE>